RCUS•benzinga•
HC Wainwright & Co. Maintains Neutral on Arcus Biosciences, Lowers Price Target to $18
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 18, 2025 by benzinga